/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Achillion Pharmaceuticals Inc.\n \n\n\n\n\n
Nov 23 12:52 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 17, 2009 4:00 PM EST
\n\n \n Achillion Receives Notice From NASDAQ - GlobeNewswire\n \n \n
\n\n Nov 06, 2009 7:00 AM EST
\n\n \n Achillion Reports Third Quarter Results - GlobeNewswire\n \n \n
\n\n Oct 29, 2009 4:01 PM EDT
\n\n \n Achillion to Present at Three Upcoming Conferences - GlobeNewswire\n \n \n
\n\n Sep 28, 2009 7:01 AM EDT
\n\n \n Achillion Completes Phase 1a Trial of ACH-1625; Begins Dosing in Phase 1b Segment With HCV-Infected Patients - GlobeNewswire\n \n \n
\n\n Sep 03, 2009 4:01 PM EDT
\n\n \n Achillion to Present At the Thomas Weisel Partners Annual Healthcare Conference - GlobeNewswire\n \n \n
\n\n Aug 03, 2009 7:00 AM EDT
\n\n \n Achillion to Present At the Canaccord Adams 29th Annual Global Growth Conference - GlobeNewswire\n \n \n
\n\n Jul 30, 2009 4:02 PM EDT
\n\n \n Achillion Reports Second Quarter and Six Month Financial Results - GlobeNewswire\n \n \n
\n
\n\n");